Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,580
Total Claims
$1.8M
Drug Cost
170
Beneficiaries
$11K
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+813%
Cost per patient vs peers
$11K vs $1,174 avg
+17%
Brand preference vs peers
10.3% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Cost per patient is 813% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Brand vs Generic
Brand: 887 claims · $1.6M
Generic: 7,693 claims · $179K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Aripiprazole | 141 | $373K |
| Paliperidone Palmitate | 107 | $338K |
| Deutetrabenazine | 42 | $329K |
| Aripiprazole Lauroxil | 73 | $215K |
| Lurasidone Hcl | 88 | $91K |
| Cariprazine Hcl | 67 | $39K |
| Risperidone | 12 | $35K |
| Brexpiprazole | 14 | $31K |
| Olanzapine/Samidorphan Malate | 16 | $25K |
| Lurasidone Hcl | 99 | $18K |
| Vortioxetine Hydrobromide | 54 | $18K |
| Esketamine Hcl | 19 | $17K |
| Lisdexamfetamine Dimesylate | 37 | $15K |
| Topiramate | 27 | $15K |
| Aripiprazole | 300 | $14K |
Prescribing Profile
72
Unique Drugs
24.0
Anomaly Score
Patient Profile
51
Avg Age
54%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About